Literature DB >> 4341918

The antiviral activity of isoprinosine.

P Gordon, E R Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341918     DOI: 10.1139/m72-224

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


× No keyword cloud information.
  9 in total

1.  Evaluation of isoprinosine in experimental human rhinovirus infection.

Authors:  D M Pachuta; Y Togo; R B Hornick; A R Schwartz; S Tominaga
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

2.  Depressed 3H-thymidine incorporation by measles infected mononuclear cells can be corrected by treatment with isoprinosine or 5-fluoro-2-deoxyuridine.

Authors:  R Lomnitzer; A R Rabson
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.

Authors:  M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

Review 4.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

5.  Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.

Authors:  H Ohnishi; H Kosuzume; H Inaba; M Okura; Y Morita; H Mochizuki; Y Suzuki
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

6.  Anti-herpesvirus action of isoprinosine.

Authors:  P Gordon; B Ronsen; E R Brown
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

7.  Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers.

Authors:  S Longley; R L Dunning; R H Waldman
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

Review 8.  Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.

Authors:  Jiri Sliva; Chrysoula N Pantzartzi; Martin Votava
Journal:  Adv Ther       Date:  2019-06-05       Impact factor: 3.845

Review 9.  Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.

Authors:  Jiří Beran; Marián Špajdel; Jiří Slíva
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.